North America Skin Antiseptic Market Size, Share & Industry Trends Analysis Report By Type (Alcohol, Chlorhexidine, Iodine), By Distribution Channel, By Form (Solutions, Swab Sticks, Cream), By Country and Growth Forecast, 2023 - 2029
The North America Skin Antiseptic Market would witness market growth of 6.1% CAGR during the forecast period (2023-2029).
The surge in sports and traffic accident injuries is also projected to fuel the demand for skin antiseptics. Due to exposure to the outside environment, soil, dust, and debris that contain a variety of microorganisms, such injuries can result in open wounds, abrasions, and lacerations, which account for the elevated risk of infections. Skin antiseptics thus contribute significantly to lowering the risk of infections and accelerating wound healing, which is projected to fuel market expansion.
Hospitals and medical facilities should adhere to thorough cleaning and disinfection practices for the endoscopes or other equipment employed during the process in order to prevent hospital-acquired infections caused by endoscopy. Moreover, to avoid spreading infections, healthcare workers should use the proper antiseptic & disinfectant solutions and follow stringent hand hygiene procedures.
According to the CDC's healthcare-associated infection (HAI) prevalence survey, inpatient surgeries were thought to be the cause of 110,800 surgical site infections (SSIs) in 2015. Almost a 3% increase in the SSI standardized infection ratio (SIR) associated with all NHSN surgical procedure categories combined compared with the previous year was recorded in 2021, according to the HAI data results for 2021 published in the NHSN's HAI Progress Report. As a result, the need for skin antiseptics in the region has increased due to the rising risk of hospital-acquired infections or surgical site infections in North America.
The US market dominated the North America Skin Antiseptic Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $597.9 million by 2029. The Canada market is poised to grow at a CAGR of 8.5% during (2023 - 2029). Additionally, The Mexico market would showcase a CAGR of 7.6% during (2023 - 2029).
Based on Type, the market is segmented into Alcohol, Chlorhexidine, Iodine and Others. Based on Distribution Channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies and Online Providers. Based on Form, the market is segmented into Solutions, Swab Sticks, Cream and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include XTTRIUM Laboratories, Sirmaxo Chemicals Private Limited, SCHÜLKE & Mayr GmbH, MÖLNLYCKE Health Care (Investor AB), Cardinal Health, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, 3M Company, PDI Healthcare, Inc. and Ecolab, Inc.
Scope of the Study
Market Segments covered in the Report:
By Type
Alcohol
Chlorhexidine
Iodine
Others
By Distribution Channel
Drug Stores & Retail Pharmacies
Hospital Pharmacies
Online Providers
By Form
Solutions
Swab Sticks
Cream
Others
By Country
US
Canada
Mexico
Rest of North America
Companies Profiled
XTTRIUM Laboratories
Sirmaxo Chemicals Private Limited
SCHÜLKE & Mayr GmbH
MÖLNLYCKE Health Care (Investor AB)
Cardinal Health, Inc.
Becton, Dickinson and Company
B. Braun Melsungen AG
3M Company
PDI Healthcare, Inc.
Ecolab, Inc.
Unique Offerings from KBV Research
Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free